Literature DB >> 22695735

The role of obesity in cancer survival and recurrence.

Wendy Demark-Wahnefried1, Elizabeth A Platz, Jennifer A Ligibel, Cindy K Blair, Kerry S Courneya, Jeffrey A Meyerhardt, Patricia A Ganz, Cheryl L Rock, Kathryn H Schmitz, Thomas Wadden, Errol J Philip, Bruce Wolfe, Susan M Gapstur, Rachel Ballard-Barbash, Anne McTiernan, Lori Minasian, Linda Nebeling, Pamela J Goodwin.   

Abstract

Obesity and components of energy imbalance, that is, excessive energy intake and suboptimal levels of physical activity, are established risk factors for cancer incidence. Accumulating evidence suggests that these factors also may be important after the diagnosis of cancer and influence the course of disease, as well as overall health, well-being, and survival. Lifestyle and medical interventions that effectively modify these factors could potentially be harnessed as a means of cancer control. However, for such interventions to be maximally effective and sustainable, broad sweeping scientific discoveries ranging from molecular and cellular advances, to developments in delivering interventions on both individual and societal levels are needed. This review summarizes key discussion topics that were addressed in a recent Institute of Medicine Workshop entitled, "The Role of Obesity in Cancer Survival and Recurrence"; discussions included (i) mechanisms associated with obesity and energy balance that influence cancer progression; (ii) complexities of studying and interpreting energy balance in relation to cancer recurrence and survival; (iii) associations between obesity and cancer risk, recurrence, and mortality; (iv) interventions that promote weight loss, increased physical activity, and negative energy balance as a means of cancer control; and (v) future directions. ©2012 AACR.

Entities:  

Mesh:

Year:  2012        PMID: 22695735      PMCID: PMC3415558          DOI: 10.1158/1055-9965.EPI-12-0485

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.254


  132 in total

Review 1.  Energetics in colorectal and prostate cancer.

Authors:  Jeffrey A Meyerhardt; Jing Ma; Kerry S Courneya
Journal:  J Clin Oncol       Date:  2010-07-19       Impact factor: 44.544

Review 2.  Nutrition and physical activity guidelines for cancer survivors.

Authors:  Cheryl L Rock; Colleen Doyle; Wendy Demark-Wahnefried; Jeffrey Meyerhardt; Kerry S Courneya; Anna L Schwartz; Elisa V Bandera; Kathryn K Hamilton; Barbara Grant; Marji McCullough; Tim Byers; Ted Gansler
Journal:  CA Cancer J Clin       Date:  2012-04-26       Impact factor: 508.702

3.  Fasting C-peptide levels and death resulting from all causes and breast cancer: the health, eating, activity, and lifestyle study.

Authors:  Melinda L Irwin; Catherine Duggan; Ching-Yun Wang; Ashley Wilder Smith; Anne McTiernan; Richard N Baumgartner; Kathy B Baumgartner; Leslie Bernstein; Rachel Ballard-Barbash
Journal:  J Clin Oncol       Date:  2010-11-29       Impact factor: 44.544

4.  Effect of obesity on prognosis after early-stage breast cancer.

Authors:  Marianne Ewertz; Maj-Britt Jensen; Katrín Á Gunnarsdóttir; Inger Højris; Erik H Jakobsen; Dorte Nielsen; Lars E Stenbygaard; Ulla B Tange; Søren Cold
Journal:  J Clin Oncol       Date:  2010-11-29       Impact factor: 44.544

Review 5.  Diabetes mellitus and breast cancer outcomes: a systematic review and meta-analysis.

Authors:  Kimberly S Peairs; Bethany B Barone; Claire F Snyder; Hsin-Chieh Yeh; Kelly B Stein; Rachel L Derr; Frederick L Brancati; Antonio C Wolff
Journal:  J Clin Oncol       Date:  2010-11-29       Impact factor: 44.544

6.  Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults.

Authors:  Eugenia E Calle; Carmen Rodriguez; Kimberly Walker-Thurmond; Michael J Thun
Journal:  N Engl J Med       Date:  2003-04-24       Impact factor: 91.245

Review 7.  Diet and survival after prostate cancer diagnosis.

Authors:  Susan E Berkow; Neal D Barnard; Gordon A Saxe; Trulie Ankerberg-Nobis
Journal:  Nutr Rev       Date:  2007-09       Impact factor: 7.110

8.  Look AHEAD (Action for Health in Diabetes): design and methods for a clinical trial of weight loss for the prevention of cardiovascular disease in type 2 diabetes.

Authors:  Donna H Ryan; Mark A Espeland; Gary D Foster; Steven M Haffner; Van S Hubbard; Karen C Johnson; Steven E Kahn; William C Knowler; Susan Z Yanovski
Journal:  Control Clin Trials       Date:  2003-10

9.  Insulin, the insulin-like growth factor axis, and mortality in patients with nonmetastatic colorectal cancer.

Authors:  Brian M Wolpin; Jeffrey A Meyerhardt; Andrew T Chan; Kimmie Ng; Jennifer A Chan; Kana Wu; Michael N Pollak; Edward L Giovannucci; Charles S Fuchs
Journal:  J Clin Oncol       Date:  2008-12-08       Impact factor: 44.544

10.  Insulin and insulin-like growth factor 1 stimulate proliferation of metastatic variants of colon carcinoma 26.

Authors:  M Koenuma; T Yamori; T Tsuruo
Journal:  Jpn J Cancer Res       Date:  1989-01
View more
  122 in total

1.  Dietary experiences and support needs of women who gain weight following chemotherapy for breast cancer.

Authors:  Alastair Kwok; Claire Palermo; Anna Boltong
Journal:  Support Care Cancer       Date:  2014-11-16       Impact factor: 3.603

2.  Impact of the AYA HOPE Comorbidity Index on Assessing Health Care Service Needs and Health Status among Adolescents and Young Adults with Cancer.

Authors:  Xiao-Cheng Wu; Pinki K Prasad; Ian Landry; Linda C Harlan; Helen M Parsons; Charles F Lynch; Ashley W Smith; Ann S Hamilton; Theresa H M Keegan
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2015-09-29       Impact factor: 4.254

3.  Effect of a six-month yoga exercise intervention on fitness outcomes for breast cancer survivors.

Authors:  Daniel C Hughes; Nydia Darby; Krystle Gonzalez; Terri Boggess; Ruth M Morris; Amelie G Ramirez
Journal:  Physiother Theory Pract       Date:  2015       Impact factor: 2.279

4.  A diagnosis of prostate cancer and pursuit of active surveillance is not followed by weight loss: potential for a teachable moment.

Authors:  M A Liss; J M Schenk; A V Faino; L F Newcomb; H Boyer; J D Brooks; P R Carroll; A Dash; M D Fabrizio; M E Gleave; P S Nelson; M L Neuhouser; J T Wei; Y Zheng; J L Wright; D W Lin; I M Thompson
Journal:  Prostate Cancer Prostatic Dis       Date:  2016-07-19       Impact factor: 5.554

5.  Serum antioxidant capacity, biochemical profile and body composition of breast cancer survivors in a randomized Mediterranean dietary intervention study.

Authors:  Maria Skouroliakou; D Grosomanidis; P Massara; C Kostara; P Papandreou; D Ntountaniotis; G Xepapadakis
Journal:  Eur J Nutr       Date:  2017-06-20       Impact factor: 5.614

Review 6.  Impact of obesity on chemotherapy management and outcomes in women with gynecologic malignancies.

Authors:  Neil S Horowitz; Alexi A Wright
Journal:  Gynecol Oncol       Date:  2015-04-12       Impact factor: 5.482

Review 7.  Adipocyte and lipid metabolism in cancer drug resistance.

Authors:  Yihai Cao
Journal:  J Clin Invest       Date:  2019-07-02       Impact factor: 14.808

8.  Preventing weight gain in African American breast cancer survivors using smart scales and activity trackers: a randomized controlled pilot study.

Authors:  Carmina G Valle; Allison M Deal; Deborah F Tate
Journal:  J Cancer Surviv       Date:  2016-09-08       Impact factor: 4.442

Review 9.  Protective effects of short-term dietary restriction in surgical stress and chemotherapy.

Authors:  Sebastian Brandhorst; Eylul Harputlugil; James R Mitchell; Valter D Longo
Journal:  Ageing Res Rev       Date:  2017-02-20       Impact factor: 10.895

10.  Coffee Intake, Recurrence, and Mortality in Stage III Colon Cancer: Results From CALGB 89803 (Alliance).

Authors:  Brendan J Guercio; Kaori Sato; Donna Niedzwiecki; Xing Ye; Leonard B Saltz; Robert J Mayer; Rex B Mowat; Renaud Whittom; Alexander Hantel; Al Benson; Daniel Atienza; Michael Messino; Hedy Kindler; Alan Venook; Frank B Hu; Shuji Ogino; Kana Wu; Walter C Willett; Edward L Giovannucci; Jeffrey A Meyerhardt; Charles S Fuchs
Journal:  J Clin Oncol       Date:  2015-08-17       Impact factor: 44.544

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.